Humate-P Purple Book BLA 103960

BLA number
103960
Proprietary names
Humate-P
Proper names
Antihemophilic Factor/von Willebrand Factor Complex (Human)
Applicant
CSL Behring GmbH
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)351(a)1000IUFor InjectionIntravenousSingle-Dose VialRxLicensed2000-04-11
002Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)351(a)250IUFor InjectionIntravenousSingle-Dose VialRxLicensed2000-04-11
003Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)351(a)500IUFor InjectionIntravenousSingle-Dose VialRxLicensed2000-04-11

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2021-09-01U001Humate-P351(a)RxCSL Behring GmbH
2021-09-01U002Humate-P351(a)RxCSL Behring GmbH
2021-09-01U003Humate-P351(a)RxCSL Behring GmbH
2021-05-01U001Humate-P351(a)RxCSL Behring GmbH
2021-05-01U002Humate-P351(a)RxCSL Behring GmbH
2021-05-01U003Humate-P351(a)RxCSL Behring GmbH
2020-08-01R001Humate-P351(a)RxCSL Behring GmbH
2020-08-01R002Humate-P351(a)RxCSL Behring GmbH
2020-08-01R003Humate-P351(a)RxCSL Behring GmbH

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Humate-P351(a)RxLicensed2000-04-11
2020-08-01002Humate-P351(a)RxLicensed2000-04-11
2020-08-01003Humate-P351(a)RxLicensed2000-04-11